Clinical TrialsSearch results
Number of results: 854
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).
- Non-small Cell Lung Cancer
- Hibi Kazushige
- 2024-03-06
Recruiting
- Effects of GHRP-2 test on hormone secretion kinetics
- Adult growth hormone deficiency
- Taguchi Tomomi
- 2024-02-28
Not yet recruiting
- Development of pharmacokinetic simulator for adrenaline infusion
- Left ventricular dysfunction, Aortic/Mitral valve stenosis, Aortic/Mitral valve regurgitation
- Sasaki Makoto
- 2024-02-27
Recruiting
- Phase2 study of mFOLFOX6 plus nivolumab for patients with ESCC
- Esophageal Cancer
- Kubota Yohei
- 2024-02-14
Other
- A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
- Respiratory Syncytial Virus Infection
- Kawai Norisuke
- 2024-02-14
Recruiting
- Exploratory Study on Measuring Amount of Brain AMPA Receptor Before and After Cochlear Implantation
- Patients with bilateral severe sensorineural hearing loss and scheduled for cochlear implant surgery
- Abe Hiroki
- 2024-02-06
Recruiting
- PSMA-DC: An Open-label study comparing lutetium (177Lu) vipivotide tetraxetan (also known as [177Lu]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617) versus observation in PSMA positive OMPC (CAAA617D12302).
- Oligometastatic Prostate Cancer (OMPC) by PSMA PET, M1 negative by CI.
- Yamauchi Kyosuke
- 2024-01-31
Not yet recruiting
- A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Plaque psoriasis
- Nakano Masayoshi
- 2024-01-26
Recruiting
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Ulcerative Colitis
- Kawai Norisuke
- 2024-01-22
Recruiting
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
- Plaque Psoriasis
- Shikamura Mitsuhiro
- 2024-01-22